<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Mesenteric <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (MVT) is a rare condition with a challenging diagnosis </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to evaluate its association with <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic diseases</z:e> and <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY: Out of 132 patients operated on because of <z:e sem="disease" ids="C0920157" disease_type="Disease or Syndrome" abbrv="">mesenteric ischemia</z:e> between 1988 and 2002, <z:hpo ids='HP_0000001'>all</z:hpo> patients with a documented MVT were retrospectively recorded </plain></SENT>
<SENT sid="3" pm="."><plain>Epidemiological and clinical data, complications and perioperative mortality were analyzed </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Twenty-one patients, 10 male and 11 female, had MVT </plain></SENT>
<SENT sid="5" pm="."><plain>Mean age was 63.8 years (SD: +/- 20.9) </plain></SENT>
<SENT sid="6" pm="."><plain>Arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> (57.1%) was the most prevalent associated condition </plain></SENT>
<SENT sid="7" pm="."><plain>Other associated disorders were <z:hpo ids='HP_0002664'>neoplasms</z:hpo> (3 cases), liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> (1 case), recurrent pulmonary <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (1 case), and one or more <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorders</z:e> (7 cases): <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (2 cases); factor V Leiden (2 cases); <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> (3 cases); <z:hpo ids='HP_0001976'>antithrombin III deficiency</z:hpo> (1 case) and <z:hpo ids='HP_0005521'>disseminated intravascular coagulation</z:hpo> (1 case) </plain></SENT>
<SENT sid="8" pm="."><plain>Perioperative mortality was 33.3% (7 patients) </plain></SENT>
<SENT sid="9" pm="."><plain>Mean survival at the end of the study was 65.73 months (EE: 13.82) </plain></SENT>
<SENT sid="10" pm="."><plain>Patients with a <z:e sem="disease" ids="C0005779" disease_type="Disease or Syndrome" abbrv="">coagulation disorder</z:e> had a higher survival rate than those presenting without it (p = 0.02) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: MVT is still a lethal condition with a high morbidity that could be associated to systemic disorders and <z:hpo ids='HP_0100724'>hypercoagulability</z:hpo> syndromes in more than 50% of the cases </plain></SENT>
</text></document>